PSMAfore Results: [177Lu]Lu-PSMA-617 in Taxane-Naive Patients With mCRPC GU Oncology Now 10:20 5 months ago 336 Далее Скачать
Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore study European Society for Medical Oncology (ESMO) 3:25 1 year ago 1 709 Далее Скачать
PSMAfore Trial & Enzalutamide with 177Lu-PSMA-617 for mCRPC | Dr. Dharmender Malik | 05th Knowledge CRSF - Cancer Research and Statistic Foundation 11:39 3 months ago 27 Далее Скачать
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-p... ecancer 4:41 5 months ago 134 Далее Скачать
Taxane-naïve metastatic castration-resistant prostate cancer, the PSMAfore trial OncoInfoTV 2:52 1 year ago 198 Далее Скачать
VISION: tolerability of 177Lu-PSMA-617 by treatment exposure in patients with mCRPC VJOncology 3:03 2 years ago 749 Далее Скачать
Fractionated dose 177Lu-PSMA-617 in patients with mCRPC VJOncology 5:30 3 years ago 265 Далее Скачать
ASCO 2024 highlights: the PSMAfore trial for patients with mCRPC VJOncology 0:33 5 months ago 122 Далее Скачать
TheraP Trial and Effectiveness of Lu-PSMA-617 Grand Rounds in Urology 4:00 3 years ago 475 Далее Скачать
PSMAfore: Radioligand Therapy in the Future of Prostate Cancer Treatment GU Oncology Now 10:56 3 weeks ago 108 Далее Скачать
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ecancer 4:28 1 year ago 407 Далее Скачать
177Lu-PSMA-617 for prostate cancer: TheraP, VISION, UpFrontPSMA and LuTectomy VJOncology 6:45 3 years ago 1 806 Далее Скачать
Lu-PSMA-617 deployment and future of prostate cancer treatment VJOncology 1:34 3 years ago 470 Далее Скачать
The development and results of a dose-intense regimen using 177Lu-PSMA-617 for progressive mCRPC VJOncology 2:02 5 months ago 60 Далее Скачать
